Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT3 | O60678 | 1/20 | 0.39 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.39 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.39 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.39 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.32 |
| ▸ | KDM4A | O75164 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1831919 | 0.87 | CA12 (0.39) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL1834034 | 0.84 | CA12 (0.41) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL15798319 | 0.82 | OPRM1 (0.41) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL15616384 | 0.81 | — | — | |
| SCHEMBL16622924 | 0.81 | CA12 (0.45) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL10123339 | 0.80 | PRMT3 (0.37) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL1831672 | 0.80 | PRMT3 (0.37) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL1834944 | 0.80 | LMNA (0.38) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL18056397 | 0.80 | PRMT3 (0.37) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL24554276 | 0.80 | ALOX15 (0.39) | LMNAALDH1A1ALDH2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2323145-A1 | Electrolytic solution for electrolytic capacitor and electrolytic capacitor as well as method for preparing an organic onium tetrafluoroaluminate | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-05-18 | — | — | EP | claimed |
| CN-100466122-C | Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEM CORP (JP) | 2009-03-04 | — | — | CN | claimed |
| US-7397651-B2 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-07-08 | — | — | US | claimed |
| US-20070188977-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-08-16 | — | — | US | claimed |
| US-20060007629-A1 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-01-12 | — | — | US | claimed |
| CN-1708817-A | Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEM CORP (JP) | 2005-12-14 | — | — | CN | claimed |
| EP-1564768-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | Mitsubishi Chemical Corporation (JP) | 2005-08-17 | — | — | EP | claimed |
| CN-117441219-A | Electrolyte for electrolytic capacitor, electrolytic capacitor using the same, and hybrid electrolytic capacitor | 三洋化成工业株式会社 | 2024-01-23 | — | — | CN | disclosed |
| EP-3950685-A1 | PYRAZOLOPYRIDINE COMPOUND AS RET INHIBITOR AND APPLICATION THEREOF | Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory (CN) | 2022-02-09 | — | — | EP | disclosed |
| EP-2843673-B1 | ELECTROLYTIC SOLUTION FOR ALUMINUM ELECTROLYTIC CAPACITOR, AND ALUMINUM ELECTROLYTIC CAPACITOR USING SAME | SANYO CHEMICAL IND LTD (JP) | 2019-01-16 | — | — | EP | disclosed |
| US-9691552-B2 | Electrolytic solution for aluminum electrolytic capacitor, and aluminum electrolytic capacitor using same | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-27 | — | — | US | disclosed |
| EP-2678349-B1 | C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE | TAISHO PHARMACEUTICAL CO LTD (JP) | 2016-01-13 | — | — | EP | disclosed |
| US-9139609-B2 | C-4″ position substituted macrolide derivative | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2015-09-22 | — | — | US | disclosed |
| US-7227738-B2 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-06-05 | — | — | US | disclosed |
| WO-2007015809-A2 | HIV REVERSE TRANSCRIPTASE INHIBITORS | MERCK & CO., INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| WO-2007015812-A2 | HIV REVERSE TRANSCRIPTASE INHIBITORS | MERCK & CO., INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| US-20070021442-A1 | HIV reverse transcriptase inhibitors | MERCK SHARP & DOHME CORP. | 2007-01-25 | — | — | US | disclosed |
| US-20060007629-A1 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-01-12 | — | — | US | disclosed |
| CN-1708817-A | Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEM CORP (JP) | 2005-12-14 | — | — | CN | disclosed |
| EP-1564768-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | Mitsubishi Chemical Corporation (JP) | 2005-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021442-A1 | HIV reverse transcriptase inhibitors | POLRMT, RNGTT, POLR2E | PRMT3 1013/4885CARM1 894/4885PRMT6 1718/4885 |
| US-20070188977-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | AFF2, CACNA2D2, AFF4 | PRMT3 2483/4885CARM1 1070/4885PRMT6 1855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.